Cullinan Oncology LLC

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
Gross Profit
-77
-76
-77
EBITDA
-49,950
-42,913
-45,408
EBIT
-50,027
-42,989
-45,485
Net Income
-42,028
-37,148
-23,803
Net Change In Cash
0
0
0
Free Cash Flow
-36,291
-38,247
-18,131
Cash
115,021
74,228
98,434
Basic Shares
55,052
43,011
42,794

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$18,943
$18,943
Gross Profit
-310
-93
18,943
-62
EBITDA
-190,339
151,409
-67,901
-60,273
EBIT
-190,649
151,316
-67,954
-60,335
Net Income
-153,162
111,214
-65,040
-50,849
Net Change In Cash
0
0
18,943
18,943
Cost of Revenue
96,378
-108,424
Free Cash Flow
-134,483
-127,797
-44,022
-29,782
Cash
98,434
550,118
430,863
168,198
Basic Shares
41,550
46,640
44,292
43,516

Earnings Calls

Quarter EPS
2024-09-30
-$0.69
2024-06-30
-$0.75
2024-03-31
-$0.86
2023-12-31
-$0.54